OneMedNet financials
$6.33+873.85%
Close Sep 28, 2026 · split-adjustedToday's change is unusually large and no split is on record yet; it may reflect an unadjusted corporate action.
Revenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 |
|---|---|---|---|
| Revenue | $1.4M | $643.0K | $1.0M |
| Gross profit | -$503.0K | -$281.0K | -$129.0K |
| Gross margin | −37.0% | −43.7% | −12.6% |
| Operating income | -$9.7M | -$9.6M | -$6.9M |
| Net income | -$2.8M | -$10.1M | -$33.8M |
| Net margin | −206.1% | −1575.3% | −3308.5% |
| Diluted EPS | $-0.06 | $-0.36 | $-4.65 |
| EBITDA | -$9.6M | -$9.5M | -$6.8M |
| Operating cash flow | -$7.5M | -$7.0M | -$4.8M |
| Free cash flow | -$7.5M | -$7.0M | -$4.8M |
| Diluted shares | 44.5M | 28.1M | 7.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $585.0K | $172.0K | $47.0K |
| Short-term investments | $506.0K | $2.8M | $0.00 |
| Total debt | $974.0K | $7.1M | $5.1M |
| Total assets | $2.2M | $3.7M | $464.0K |
| Total liabilities | $5.1M | $19.7M | $13.9M |
| Shareholders' equity | -$3.0M | -$15.9M | -$13.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology